UE LifeSciences

Medical Devices & EquipmentSeries APhiladelphia, USuelifesciences.com

Latest round

Series A

Last raised

Sep 2015

Total raised

$3.1M

Investors

2

About UE LifeSciences

UE LifeSciences Inc.Founded in 2009 and headquartered in Philadelphia, US, UE LifeSciences Inc. specializes in innovative medical devices designed for early cancer detection. The company has not undergone any significant pivots in its business strategy. It was co-founded by Bhaumik Sanghvi, Matthew Campisi, and Mihir Shah, with Madhukumar K currently serving as CEO.UE LifeSciences specializes in innovative, non-invasive medical devices aimed at enhancing early cancer detection. Their flagship offerings include iBreastExam, a portable breast cancer screening tool, and CervAIcal, a mobile colposcope for cervical cancer assessment. These tools are designed for use by community health workers and are characterized by their ease of use, requiring minimal training, and their ability to operate offline, providing instant results with high efficacy. UE LifeSciences targets a diverse client base that includes government health departments, healthcare providers, and non-governmental organizations across multiple markets, including India, Malaysia, Colombia, and South Africa.UE LifeSciences generates revenue through partnerships and direct sales of its medical devices to healthcare providers and organizations. The company’s transactions are structured around B2B arrangements, where clients purchase the iBreastExam and CervAIcal tools, enabling broader access to early cancer detection services. These devices may be sold as part of a comprehensive package that includes training and support services, enhancing their value proposition. Given the diverse healthcare settings in which these products are employed, UE LifeSciences collaborates with governments and healthcare organizations to ensure that its offerings meet local health needs effectively. The company aims to develop additional medical devices targeting various forms of cancer, with plans for launch within the next few years. Specifically, UE LifeSciences is focusing on expanding its presence in Asia and Latin America by 2025, aiming to establish partnerships with local health organizations to streamline access to its innovative solutions.

Who invested in UE LifeSciences

2 investors across 2 rounds

See all investors in UE LifeSciences

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Sep 14, 2015

    Amount

    $3M

    Investors

    Locked

  2. Seed

    May 21, 2015

    Amount

    $0.1M

    Investors

    Locked

Questions about UE LifeSciences

Who invested in UE LifeSciences?

UE LifeSciences has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has UE LifeSciences raised?

UE LifeSciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did UE LifeSciences last raise money?

UE LifeSciences's most recent round on record is a Series A, in Sep 2015.

What does UE LifeSciences do?

UE LifeSciences is a medical devices & equipment company.

Where is UE LifeSciences headquartered?

UE LifeSciences is headquartered in Philadelphia, US.

Which VCs invest in companies like UE LifeSciences?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at UE LifeSciences's stage. Their profiles are linked below.

Raising like UE LifeSciences? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.